Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Meet the Little-Known Chinese CAR-T Biotech Up More Than 500% Since June 2017

  • Post author:Sam
  • Post published:February 13, 2018
  • Post category:BioPharma

The company reported positive results from early studies in 35 patients with a type of blood cancer last year. Source: BioSpace

Continue ReadingMeet the Little-Known Chinese CAR-T Biotech Up More Than 500% Since June 2017

FDA Berates Bayer for Inadequate Cleaning, QC Questions at HQ

  • Post author:Sam
  • Post published:February 13, 2018
  • Post category:BioPharma

The company is addressing the FDA’s complaints regarding manufacturing practices, which stem from a routine inspection in January, Source: BioSpace

Continue ReadingFDA Berates Bayer for Inadequate Cleaning, QC Questions at HQ

Jobs Affected as ImmunoGen Winds Down Ops at Massachusetts Facility

  • Post author:Sam
  • Post published:February 13, 2018
  • Post category:BioPharma

ImmunoGen gave a pipeline progress report and 2017 operating results last week. Source: BioSpace

Continue ReadingJobs Affected as ImmunoGen Winds Down Ops at Massachusetts Facility

Japan's Astellas Pays $102.5M for U.S. Biotech Universal Cells

  • Post author:Sam
  • Post published:February 13, 2018
  • Post category:BioPharma

Astellas will gain Universal Cells' proprietary Universal Donor Cell technology to create cell therapy products that do not require HLA matching. Source: BioSpace

Continue ReadingJapan's Astellas Pays $102.5M for U.S. Biotech Universal Cells

Vertex Scores FDA Nod for CF Combo Drug, Sets $292,000 Price Tag

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

The FDA approved Vertex's Symdeko for cystic fibrosis in patients ages 12 and older with two copies of the F508del mutation. Source: BioSpace

Continue ReadingVertex Scores FDA Nod for CF Combo Drug, Sets $292,000 Price Tag

Charles River Slams Down $800M Cash for Global CRO

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

The acquisition will strengthen Charles River's position as a global early-stage CRO, expanding its client base and service portfolio. Source: BioSpace

Continue ReadingCharles River Slams Down $800M Cash for Global CRO

It's Confirmed: Celgene's Former CEO and Chairman is Making a Run for the Senate

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

Bob Hugin announced his campaign on Monday in an email. Source: BioSpace

Continue ReadingIt's Confirmed: Celgene's Former CEO and Chairman is Making a Run for the Senate

AI Biotech, BioXcel Therapeutics, Files for $69M IPO

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

The Branford, CT-based company was founded in 2017 and plans to list on the Nasdaq under the symbol BTAI. Source: BioSpace

Continue ReadingAI Biotech, BioXcel Therapeutics, Files for $69M IPO

Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace

Continue ReadingPurdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis

Walgreens Makes a Takeover Play for Drug Distributor AmerisourceBergen

  • Post author:Sam
  • Post published:February 12, 2018
  • Post category:BioPharma

AmerisourceBergen is one of the biggest drug distributors in the U.S. Source: BioSpace

Continue ReadingWalgreens Makes a Takeover Play for Drug Distributor AmerisourceBergen
  • Go to the previous page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.